Skip to main content
SpringerLink
Log in

The Role of Growth Factors in Diabetic Kidney Disease

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

  • 112 Accesses

Abstract

Growth factors have attracted attention in several areas of diabetes research including conceivable effects on the renal changes seen in experimental and human diabetes. In our review article published in The Kidney and Hypertension in Diabetes Mellitus, Second Edition, 1994 we covered the published evidence for a connection between changes in various growth factors (growth hormone (GH), insulin-like growth factors (IGFs), epidermal growth factor (EGF), transforming growth factor β (TGF-β), platelet derived growth factor (PDGF), tumor necrosis factor α (TNF-α) and fibroblastic growth factors (FGFs)) and the development of renal changes in diabetes. Almost every month there are several new papers on the possible relationship between growth factors and the development of diabetic nephropathy, which makes it progressively more difficult to write an ‘up-to-date’ review on the topic, and not all papers can be discussed in detail here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Flyvbjerg A. The growth hormone/insulin-like growth factor axis in the kidney: Aspects in relation to chronic renal failure. J Pediatr Endocrinol 1994; 7: 85–92.

    CAS  PubMed  Google Scholar 

  2. Flyvbjerg A, Landau D, Domene H, Hernandez L, Grønbök H, LeRoith D. The role of growth hormone, insulin-like growth factors (IGFs), and IGF-Binding proteins in experimental diabetic kidney disease. Metabolism 1995; 44: 67–71.

    Article  CAS  PubMed  Google Scholar 

  3. Bortz JD, Rotwein P, DeVol D, Bechtel PJ, Hansen VA, Hammerman MR. Focal expression of insulin-like growth factor I in rat kidney collecting duct. J Cell Biol 1988; 107: 811–819.

    Article  CAS  PubMed  Google Scholar 

  4. Flyvbjerg A, Marshall SM, Frystyk J, Rasch R, Bornfeldt KE, Arnqvist H, Jensen PK, Pallesen G, Ørskov H. Insulin-like growth factor I in initial renal hypertrophy in potassium-depleted rats. Am J Physiol 1992; 262: F1023–F1031.

    CAS  PubMed  Google Scholar 

  5. Landau D, Chin E, Bondy C, Domene H, Roberts CT, Grønbæk H, Flyvbjerg A, LeRoith D. Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes. Endocrinology 1995; 136: 1835–1842.

    Article  CAS  PubMed  Google Scholar 

  6. Arnqvist HJ, Ballermann BJ, King GL. Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells. Am J Physiol 1988; 254: C411–C416.

    CAS  PubMed  Google Scholar 

  7. Pillion DJ, Haskell JF, Meezan E. Distinct receptors for insulin-like growth factor I in rat renal glomeruli and tubules. Am J Physiol 1988; 255: E504–E512.

    CAS  PubMed  Google Scholar 

  8. Chin E, Bondy C. Insulin-like growth factor system gene expression in the human kidney. J Clin Endocrinol Metab 1992; 75: 962–968.

    Article  CAS  PubMed  Google Scholar 

  9. Shimasaki S, Shimonaka M, Zhang HP, Ling N. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 1991; 266: 10646–10653.

    CAS  PubMed  Google Scholar 

  10. Shimasaki S, Gao L, Shimonaka M, Ling N. Isolation and molecular cloning of insulin-like growth factor binding protein 6. Mol Endocrinol 1991; 5: 938–948.

    Article  CAS  PubMed  Google Scholar 

  11. Flyvbjerg A, Thorlacius-Ussing O, Næraa R, Ingerslev J, Ørskov H. Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 1988; 31: 310–314.

    CAS  PubMed  Google Scholar 

  12. Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, Ørskov H. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 1989; 32: 261–265.

    Article  CAS  PubMed  Google Scholar 

  13. Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist HJ, Ørskov H. Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 1990; 33: 334–338.

    Article  CAS  PubMed  Google Scholar 

  14. Flyvbjerg A, Orskov H. Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes. Acta Endocrinol (Copenh) 1990; 122: 374–378.

    CAS  Google Scholar 

  15. Werner H, Shen Orr Z, Stannard B, Burguera B, Roberts CT Jr, LeRoith D. Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney. Diabetes 1990; 39: 1490–1497.

    Article  CAS  PubMed  Google Scholar 

  16. Bornfeldt KE, Arnqvist HJ, Enberg B, Mathews LS, Norstedt G. Regulation of insulin-like growth factor I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol 1989; 122: 651–656.

    Article  CAS  PubMed  Google Scholar 

  17. Bach LA, Stevenson JL, Allen TJ, Jerums G, Herington AC. Kidney insulin-like growth factor-I mRNA levels are increased in postpubertal diabetic rats. J Endocrinol 1991; 129: 5–10.

    Article  CAS  PubMed  Google Scholar 

  18. Marshall SM, Flyvbjerg A, Frystyk J, Korsgaard L, Ørskov H. Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat. Diabetologia 1991; 34: 632–639.

    Article  CAS  PubMed  Google Scholar 

  19. Flyvbjerg A, Kessler U, Dorka B, Funk B, Ørskov H, Kiess W. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 1992; 35: 589–593.

    Article  CAS  PubMed  Google Scholar 

  20. Steer KA, Sochor M, Kunjara S, Doepfner W, McLean P. The effect of a somatostatin analogue (SMS 201-995) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat. Biochem Med Metab Biol 1988; 39: 226–233.

    Article  CAS  PubMed  Google Scholar 

  21. Grønbæk H, Nielsen B, Frystyk J, Ørskov H, Flyvbjerg A. Effect of octreotide on experimental diabetic renal and glomerular growth: Importance of early intervention. J Endocrinol 1995; 147: 95–102.

    Article  PubMed  Google Scholar 

  22. Grønbæk H, Nielsen B, Østerby R, Harris AG, Ørskov H, Flyvbjerg A. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats. Diabetologia 1995; 38: 135–144.

    Article  PubMed  Google Scholar 

  23. Grønbæk H, Nielsen B, Frystyk J, Flyvbjerg A, Ørskov H. Effect of lanreotide, a somatostatin analogue, on diabetic renal hypertrophy, kidney and serum IGF-I and IGF binding proteins. Experimental Nephrology 1996; in press.

    Google Scholar 

  24. Weiss O, Rubinger D, Nephesh I, Moshe R, Raz I. The influence of octreotide on IGF system gene expression in the kidney of diabetic rats (Abstract). Diabetologia 1995; 38: A206.

    Google Scholar 

  25. Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, Harris AG, Ørskov H. Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion. Kidney Int 1992; 41: 805–812.

    Article  CAS  PubMed  Google Scholar 

  26. Iwasaki S. Octreotide suppresses the kidney weight and glomerular hypertrophy in diabetic rats. Nippon Jinzo Gakkai Shi 1993; 35: 247–255.

    CAS  PubMed  Google Scholar 

  27. Muntzel M, Hannedouche T, Niesor R, Noel LH, Souberbielle JC, Lacour B, Drueke T. Long-term effects of a somatostatin analogue on renal haemodynamics and hypertrophy in diabetic rats. Clin Sci 1992; 83: 575–581.

    CAS  PubMed  Google Scholar 

  28. Igarashi K, Ito S, Shibata A. Effect of a somatostatin analogue (SMS 201–995) on urinary albumin excretion in streptozotocin-induced diabetic rats. J Japan Diab Soc 1990; 33: 531–538.

    CAS  Google Scholar 

  29. Igarashi K, Nakazawa A, Tani N, Yamazaki M, Ito S, Shibata A. Effect of a somatostatin analogue (SMS 201–995) on renal function and excretion in diabetic rats. J Diabetic Compl 1991; 5: 181–183.

    Article  CAS  Google Scholar 

  30. Grønbæk H, Vogel I, Lancranjan I, Flyvbjerg A, Ørskov H. Effect of octreotide, captopril, or insulin on manifest long-term experimental diabetic renal changes (Abstract). Diabetologia 1995; 38: A206.

    Article  Google Scholar 

  31. Vora J, Owens DR, Luzio SD, Atiea J, Ryder R, Hayes TM. Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects. J Clin Endocrinol Metab 1987; 64: 975–979.

    Article  CAS  PubMed  Google Scholar 

  32. Pedersen MM, Christensen SE, Christiansen JS, Pedersen EB, Mogensen CE, Ørskov H. Acute effects of a somatostatin analogue on kidney function in type 1 diabetic patients. Diabetic Med 1990; 7: 304–309.

    Article  CAS  PubMed  Google Scholar 

  33. Krempf M, Ranganathan S, Remy JP, Charbonnel B, Guillon J. Effect of a long acting somatostatin analogue (SMS 201–1995) on high glomerular filtration rate in insulin dependent diabetic patients. Int J Clin Pharmacol Ther Toxicol 1990; 28: 309–311.

    CAS  PubMed  Google Scholar 

  34. Serri O, Beauregard H, Brazeau P, Abribat T, Lambert J, Harris A, Vachon L. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 1991; 265: 888–892.

    Article  CAS  PubMed  Google Scholar 

  35. Nakamura T, Fukui M, Ebihara E, Osada S, Nagaoka I, Tomino Y, Koide H. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993; 42: 450–456.

    Article  CAS  PubMed  Google Scholar 

  36. Ziyadeh FN, Chen Y, Davila A, Goldfarb S. Self limited stimulation of mesangial cell growth in high glucose: autocrine activation of TGF-β reduces proliferation but increases mesangial matrix. Kidney Int 1992; 42: 647–656.

    Article  PubMed  Google Scholar 

  37. Choi ME, Eung-Gook K, Ballerman BJ. Rat mesangial cell hypertrophy in response to transforming growth factor β1. Kidney Int 1993; 44: 948–958.

    Article  CAS  PubMed  Google Scholar 

  38. Ziyadeh FN, Snipes ER, Watanabe M, Alvarey RJ, Goldfarb S, Haverty TP. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 1990; 259: F704–F714.

    CAS  PubMed  Google Scholar 

  39. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubules. Kidney Int 1992; 41: 107–114.

    Article  CAS  PubMed  Google Scholar 

  40. Nakamura T, Miller D, Rouslahti E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor β1. Kidney Int 1992; 41: 1213–1221.

    Article  CAS  PubMed  Google Scholar 

  41. Humes HD, Nakamura T, Cieslinski DA, Miller D, Emmons RV, Border WA. Role of protoglycans and cytoskeleton in the effects of TGF-β1 on renal proximal tubule cells. Kidney Int 1993; 43: 575–584.

    Article  CAS  PubMed  Google Scholar 

  42. Roberts AB, McCune BK, Sporn MB. TGF-β1: Regulation of extracellular matrix. Kidney Int 1992; 41: 557–559.

    Article  CAS  PubMed  Google Scholar 

  43. Davies M, Thomas GJ, Martin J, Lovett DH. The purification and characterisation of a glomerular basement membrane degrading neutral proteinase from the rat mesangial cells. Biochem J 1988; 251: 419–425.

    CAS  PubMed  Google Scholar 

  44. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJP, Angel P, Heath JK. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor (Abstract). EMBO J 1987; 6: 1899.

    CAS  PubMed  Google Scholar 

  45. Lovett DH, Marti HP, Martin J, Grond J, Kashfarian DH. Transforming growth factor β1 stimulates mesangial cell synthesis of the 72 kD type IV collagenase independent of TIMP-1 (Abstract). J Am Soc Nephrol 1991; 1:578.

    Google Scholar 

  46. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial matrix. J Clin Invest 1990; 86: 453–462.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346: 371–374.

    Article  CAS  PubMed  Google Scholar 

  48. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360: 361–364.

    Article  CAS  PubMed  Google Scholar 

  49. Ziyadeh FN, Sharma K, Ricksen N, Wolf G. Stimulation of callagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor β. J Clin Invest 1994; 93: 536–542.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Shankland SJ, Scholey JW. Expression of transforming grwoth factor β1 during diabetic renal hypertrophy. Kidney Int 1994; 46: 430–442.

    Article  CAS  PubMed  Google Scholar 

  51. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor is elevated in human and experimental diabetic glomerulopathy. Proc Natl Acad Sci USA 1993; 90: 1814–1818.

    Article  CAS  PubMed  Google Scholar 

  52. Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45: 522–530.

    Article  CAS  PubMed  Google Scholar 

  53. Korpinen E, Teppo A-M, Groop H-H, Fagerudd J, Åkerblom HK, Varala O. Elevated levels of urinary transforming growth factor-ßl in young IDDM patients (Abstract). Diabetologia 1996; 39: Suppl. 1: A293.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Research Laboratories, Institute of Experimental Clinical Research, University Hospital, Aarhus Kommunehospital, Aarhus, Denmark

    Allan Flyvbjerg, Henning Grønbæk, Martin Bak, Birgitte Nielsen, Thora Christiansen, Ida Vogel & Hans Ørskov

Authors
  1. Allan Flyvbjerg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henning Grønbæk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Bak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Birgitte Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thora Christiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ida Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hans Ørskov
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Department M (Diabetes & Endocrinology), Aarhus Kommunehospital University Hospitals in Aarhus, Aarhus C, Denmark

    Carl Erik Mogensen

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Flyvbjerg, A. et al. (1996). The Role of Growth Factors in Diabetic Kidney Disease. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6749-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6749-0_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6751-3

  • Online ISBN: 978-1-4757-6749-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation